Literature DB >> 23773923

The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer.

Lequn Li1, Vassiliki A Boussiotis.   

Abstract

The intestinal epithelium and underlying lamina propria contain T cells that play important roles in maintaining colonic homeostasis. These T cells mediate substantial and specific regulation to ensure that pathogenic microorganisms are eliminated while commensal bacteria are tolerated. There is considerable evidence supporting the notion that the altered ratio between Foxp3(+)CD4(+) T regulatory cells and T effector cells in the colonic microenvironment might contribute to the initiation and progression of inflammation and eventually development of colon cancer. Recent findings on the heterogeneity and plasticity of T regulatory cells, such as the identification of IL-17(+)Foxp3(+)CD4(+) and the RORγt(+)Foxp3(+)CD4(+) subsets, in patients with colorectal inflammation and cancer have provided a new twist in our understanding of the pathogenesis of colonic diseases. Phenotypic and functional properties of IL-17-producing Foxp3(+)CD4(+) T cells as well as the significant implications of these cells in the initiation and progression of colorectal diseases are discussed in this review.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colon cancer; IL-17; Inflammatory bowel disease; RORγt; T regulatory cells; Th17

Mesh:

Substances:

Year:  2013        PMID: 23773923      PMCID: PMC3808980          DOI: 10.1016/j.clim.2013.05.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  61 in total

1.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

2.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

3.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

4.  An essential role for Scurfin in CD4+CD25+ T regulatory cells.

Authors:  Roli Khattri; Tom Cox; Sue-Ann Yasayko; Fred Ramsdell
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

5.  Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer.

Authors:  Nichole R Blatner; Mary F Mulcahy; Kristen L Dennis; Denise Scholtens; David J Bentrem; Joseph D Phillips; Soo Ham; Barry P Sandall; Mohammad W Khan; David M Mahvi; Amy L Halverson; Steven J Stryker; Anne-Marie Boller; Ashima Singal; Rebekka K Sneed; Bara Sarraj; Mohammed Javeed Ansari; Martin Oft; Yoichiro Iwakura; Liang Zhou; Andreas Bonertz; Philipp Beckhove; Fotini Gounari; Khashayarsha Khazaie
Journal:  Sci Transl Med       Date:  2012-12-12       Impact factor: 17.956

6.  Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients.

Authors:  Adam Girardin; John McCall; Michael A Black; Francesca Edwards; Vicky Phillips; Edward S Taylor; Anthony E Reeve; Roslyn A Kemp
Journal:  Int J Cancer       Date:  2012-10-20       Impact factor: 7.396

7.  IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy.

Authors:  Erica G Schmitt; Dipica Haribhai; Jason B Williams; Praful Aggarwal; Shuang Jia; Louis-Marie Charbonnier; Ke Yan; Rachel Lorier; Amy Turner; Jennifer Ziegelbauer; Peter Georgiev; Pippa Simpson; Nita H Salzman; Martin J Hessner; Ulrich Broeckel; Talal A Chatila; Calvin B Williams
Journal:  J Immunol       Date:  2012-11-02       Impact factor: 5.422

8.  Runx1 and Runx3 are involved in the generation and function of highly suppressive IL-17-producing T regulatory cells.

Authors:  Lequn Li; Nikolaos Patsoukis; Victoria Petkova; Vassiliki A Boussiotis
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

9.  Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.

Authors:  Keiji Hayata; Makoto Iwahashi; Toshiyasu Ojima; Masahiro Katsuda; Takeshi Iida; Mikihito Nakamori; Kentaro Ueda; Masaki Nakamura; Motoki Miyazawa; Toshiaki Tsuji; Hiroki Yamaue
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

10.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.

Authors:  Janine L Coombes; Karima R R Siddiqui; Carolina V Arancibia-Cárcamo; Jason Hall; Cheng-Ming Sun; Yasmine Belkaid; Fiona Powrie
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

View more
  34 in total

1.  IL-17 induces radiation resistance of B lymphoma cells by suppressing p53 expression and thereby inhibiting irradiation-triggered apoptosis.

Authors:  Qingshan Li; Xin Xu; Weijie Zhong; Qinghua Du; Bizhen Yu; Huabao Xiong
Journal:  Cell Mol Immunol       Date:  2014-12-29       Impact factor: 11.530

Review 2.  Immunosuppression associated with chronic inflammation in the tumor microenvironment.

Authors:  Dingzhi Wang; Raymond N DuBois
Journal:  Carcinogenesis       Date:  2015-09-08       Impact factor: 4.944

Review 3.  Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells.

Authors:  Pushpa Pandiyan; Jinfang Zhu
Journal:  Cytokine       Date:  2015-07-10       Impact factor: 3.861

4.  Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.

Authors:  Ji Li; Aito Ueno; Marietta Iacucci; Miriam Fort Gasia; Humberto B Jijon; Remo Panaccione; Gilaad G Kaplan; Paul L Beck; Joanne Luider; Herman W Barkema; Jiaming Qian; Xianyong Gui; Subrata Ghosh
Journal:  Dig Dis Sci       Date:  2017-06-01       Impact factor: 3.199

Review 5.  FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.

Authors:  Changhua Zhuo; Ye Xu; Mingang Ying; Qingguo Li; Liyong Huang; Dawei Li; Sanjun Cai; Bin Li
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

6.  Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.

Authors:  Eduardo Huarte; SangMu Jun; Agnieszka Rynda-Apple; Sara Golden; Larissa Jackiw; Carol Hoffman; Massimo Maddaloni; David W Pascual
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

7.  mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production.

Authors:  Feidi Chen; Anthony Cao; Suxia Yao; Heather L Evans-Marin; Han Liu; Wei Wu; Eric D Carlsen; Sara M Dann; Lynn Soong; Jiaren Sun; Qihong Zhao; Yingzi Cong
Journal:  J Immunol       Date:  2016-04-11       Impact factor: 5.422

8.  The Alternative NF-κB Pathway in Regulatory T Cell Homeostasis and Suppressive Function.

Authors:  Yenkel Grinberg-Bleyer; Rachel Caron; John J Seeley; Nilushi S De Silva; Christian W Schindler; Matthew S Hayden; Ulf Klein; Sankar Ghosh
Journal:  J Immunol       Date:  2018-02-19       Impact factor: 5.422

9.  Activation of LANCL2 by BT-11 Ameliorates IBD by Supporting Regulatory T Cell Stability Through Immunometabolic Mechanisms.

Authors:  Andrew Leber; Raquel Hontecillas; Victoria Zoccoli-Rodriguez; Josep Bassaganya-Riera
Journal:  Inflamm Bowel Dis       Date:  2018-08-16       Impact factor: 5.325

10.  Myeloid-Derived IL-33 Limits the Severity of Dextran Sulfate Sodium-Induced Colitis.

Authors:  Li-Yin Hung; Christopher F Pastore; Bonnie Douglas; De'Broski R Herbert
Journal:  Am J Pathol       Date:  2020-11-24       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.